Overview

The Effects of Aripiprazole on Patients With Metabolic Syndrome

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to assess the effect of aripiprazole on patients who developed metabolic syndrome while taking other second generation antipsychotic medications.
Phase:
Phase 4
Details
Lead Sponsor:
New Mexico VA Healthcare System
Collaborator:
Bristol-Myers Squibb
Treatments:
Aripiprazole